CClinicalTrials.gg
CompletedNCT01718314Updated Oct 31, 2012

Comparison of Sublingual Misoprostol Versus Lidocaine Spray for Hysteroscopy

An interventional study of Sublingual Misoprostol and Lidocaine pump spray in Pain During Hysteroscopy, sponsored by Dr. Sami Ulus Children's Hospital. Completed at 1 site in Turkey. Open to female participants aged 18 Years to 51 Years. Per ClinicalTrials.gov, last updated 2012-10-31.

Sponsored by Dr. Sami Ulus Children's Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
138
Allocation
Randomized
Ages
18 Years to 51 Years
Sex
Female
01

Study summary

Hysteroscopy is an instrument to visualize the interior walls of uterus (womb) and it enables the doctor to do minor operative procedures. Although it causes little discomfort, sometimes it may be disturbing for the patient. This pain is usually perceived during the passage of the instrument through the cervix (neck of the womb). The investigators would like to minimize this pain by two drugs: Misoprotol and lidocaine

Read the detailed description

Outpatient or office hysteroscopy has become the 'gold standard' for the investigation of the intrauterine abnormalities. This minimal invasive modality provides brilliant and clear visualization of the entire uterine cavity and besides this, by the operative channel, minor procedures may easily be performed in the office setting which is priceless for the gynecologist. However, pain related to the procedure may make the procedure uncomfortable for the patient and the physician. Together with the operative time, hysteroscope diameter is considered as the main factor influencing pain. The pain perceived during hysteroscopy may be reduced by using a smaller diameter hysteroscope or by using anesthesia, which decreases pain perception.

In this prospective, randomized, double blind, placebo controlled study, we aim to compare the effectiveness of sublingual misoprostol versus lidocaine pump spray for pain relief during office hysteroscopy.

02

Conditions studied

  • Pain During Hysteroscopy

Keywords

  • Hysteroscopy
  • Misoprostol
  • Lidocaine
  • Visual analogue score
03

In context

Lead sponsor

Dr. Sami Ulus Children's Hospital is the lead sponsor of 16 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 51 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Premenopausal women in the proliferative phase of the menstrual cycle with no contraindication for hysteroscopy

Exclusion criteria

Exclusion Criteria:

  • vaginal bleeding at the time of the procedure
  • known sensitivity to lidocaine (amide group local anesthetics) or prostaglandins
  • epilepsy
  • significantly impaired respiratory or cardiac conduction functions
  • hypertension
  • glaucoma
  • renal failure
  • acute liver disease
  • uncontrolled diabetes mellitus
  • pregnancy or suspicion of pregnancy
  • pelvic inflammatory disease
  • cervical operation history
  • vaginismus.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
138 participants (actual)

Study arms

  • Experimental
    Sublingual Misoprostol & Lidocaine placebo

    Misoprostol 200 µg sublingually single dose and Lidocaine spray placebo

    Drug: Sublingual Misoprostol · Drug: Placebo (for Lidocaine)

  • Experimental
    Lidocaine Pump Spray & Misoprostol placebo

    Lidocaine Pump spray, 6 sprays to cervix (60 mg totally) and sublingual misoprotol placebo

    Drug: Lidocaine pump spray · Drug: Placebo (for Misoprostol)

Interventions

  • DrugSublingual Misoprostol

    Also known as: Cytotec

  • DrugLidocaine pump spray

    Also known as: Xylocaine %10 pump spray

  • DrugPlacebo (for Misoprostol)

    Lactose filler, the pharmacy-produced pills identical to original misoprostol pill

  • DrugPlacebo (for Lidocaine)

    The pharmacy-produced sterile saline containing pump spray external characteristics identical to lidocaine pump spray

06

What researchers measure

Primary outcomes

  1. Patient VAS score immediately after the procedure

    Time frame: Immediately after the procedure

Secondary outcomes

  1. Patient VAS score 10 minutes after the procedure

    Time frame: 10 minutes after the procedure

Other outcomes

  1. Need for cervical dilation

    Time frame: During the procedure

07

Study locations

1 site
  • Dr Sami Ulus Maternity and Children Training and Research Hospital
    Ankara, 06090, Turkey
08

References and documents

Publications

  • van Dongen H, de Kroon CD, Jacobi CE, Trimbos JB, Jansen FW. Diagnostic hysteroscopy in abnormal uterine bleeding: a systematic review and meta-analysis. BJOG. 2007 Jun;114(6):664-75. doi: 10.1111/j.1471-0528.2007.01326.x. PubMed 17516956 ↗
  • De Iaco P, Marabini A, Stefanetti M, Del Vecchio C, Bovicelli L. Acceptability and pain of outpatient hysteroscopy. J Am Assoc Gynecol Laparosc. 2000 Feb;7(1):71-5. doi: 10.1016/s1074-3804(00)80012-2. PubMed 10648742 ↗
  • Mulayim B, Celik NY, Onalan G, Bagis T, Zeyneloglu HB. Sublingual misoprostol for cervical ripening before diagnostic hysteroscopy in premenopausal women: a randomized, double blind, placebo-controlled trial. Fertil Steril. 2010 May 1;93(7):2400-4. doi: 10.1016/j.fertnstert.2009.01.073. Epub 2009 Feb 24. PubMed 19243750 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 31, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01718314
Lead sponsor
Dr. Sami Ulus Children's Hospital
Responsible party
Sertac ESIN (Obstetrician and Gynecologist, Dr. Sami Ulus Children's Hospital) — Principal investigator
First posted
Oct 31, 2012
Start date
Mar 2008
Primary completion
Dec 2009
Completion
Mar 2010
Last update
Oct 31, 2012

Study contacts

Tuncay Kucukozkan, Professor
study chair · Sami Ulus Maternity and Childrens Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion